US Pharma MarketingHHS rolls out sweeping clinical trial reforms to counter China, RFK Jr. says
HHS launches clinical trial reforms — including new pilot programs and updated FDA guidance — to accelerate US drug development and compete with China. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing:…
The Trump administration is responding to a drumbeat of calls from the biotech and pharma industries to modernize and expedite clinical trials with a sweeping initiative across HHS.
The department
Source: Endpoints News